PMI Reports Strong Performance for H1: IQOS ZYN Exceeding Expectations

PMI by 2FIRSTS.ai
Apr.24.2024
PMI Reports Strong Performance for H1: IQOS ZYN Exceeding Expectations
PMI announced strong first-quarter performance with a net income of $8.8 billion, driven by smoke-free products.

According to a report on the official website of Philip Morris International (PMI), the company announced its first quarter performance for 2024 on April 24th. The total net revenue was $8.8 billion, an increase of 9.7% from the previous year, exceeding the expected $8.468 billion; gross profit reached $5.6 billion, a 12.4% increase from the previous year, driven by strong performance in smoke-free products. Operating income was $3 billion, an 11.5% increase from the previous year, with organic growth of 22.2%. Highlights of the report include:

 

  • Reported diluted earnings per share of $1.38, a 7.8% increase from the previous year, falling below the expected $1.41. 
  • Adjusted diluted earnings per share were $1.50, an 8.7% growth, excluding currency effects it translates to $1.70, surpassing quarterly expectations. 
  • Revenue from smoke-free products accounted for 39% of total net revenue, with a 21.1% growth in this segment. 
  • A regular quarterly dividend of $1.30 per share was declared, maintaining an annualized dividend of $5.20 per share. 

 

PMI exceeded market expectations in first quarter profits and revenue, primarily due to strong demand for its heated tobacco products and ZYN nicotine pouches.

 

The flagship heated tobacco device IQOS is expected to enter the US market in the second quarter. The shipment volume of IQOS products in the first quarter was 33.1 billion, a year-on-year increase of 20.9%, compared to the previous quarter's growth rate of 6.1%.

 

PMI's smoke-free business (SFB) accounts for 39% of its total net revenue, with significant progress made in markets such as Japan and South Korea. IQOS has achieved a market share of over 29% in Japan, with increasing acceptance.

 

PMI's ZYN nicotine pouches reported strong sales performance, with canned shipment volumes increasing by 40.0% to 1.316 billion cans, a 79.7% growth compared to the same period last year. At the same time, the company also raised its forecast for shipments of nicotine pouches to the United States from an estimated 520 million cans to around 560 million cans. Net revenue organically grew by 7% to 8.5%.

 

PMI CEO Jacek Olczak stated in a press release:

 

Our strong performance in the first quarter, excellent revenue growth, and significant profit margin expansion have given us confidence to raise our currency neutral guidance for 2024. With the operational leverage of IQOS and the strong economic benefits of ZYN driving momentum in the smoke-free category, our underlying sales volume is rapidly increasing, and organic net revenue and gross profit are accelerating. In a dynamic operating environment characterized by geopolitical and economic tensions exacerbating currency fluctuations, we are executing efficiently and effectively. We are making every effort to address these challenges and achieve strong growth and value creation.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Trump Picks White House Health Policy Aide Heidi Overton to Lead FDA, Pending Senate Confirmation
Trump Picks White House Health Policy Aide Heidi Overton to Lead FDA, Pending Senate Confirmation
U.S. President Donald Trump has chosen White House health policy aide Heidi Overton to lead the Food and Drug Administration, Bloomberg reported, citing a person familiar with the matter. Overton currently works on health policy at the White House and previously held a senior role at the America First Policy Institute. If confirmed by the Senate, she would take over an FDA that has experienced months of senior-level turnover. The agency regulates products representing roughly one-fifth of U.S. consumer spending, including e-cigarettes, drugs, vaccines and much of the food supply.
News
Aug.19
How Large Is France’s Off-Channel Tobacco Market? Logista Says It Has Become Structural, While the Official Estimate Is 17.7% and Some Industry Studies Put It Above 50%
How Large Is France’s Off-Channel Tobacco Market? Logista Says It Has Become Structural, While the Official Estimate Is 17.7% and Some Industry Studies Put It Above 50%
Logista France says tobacco consumption outside France’s official tobacconist network has become a large and structural market phenomenon, but official and industry estimates differ sharply. France’s TAFE study estimates that 17.7% of tobacco consumption escaped domestic taxation in 2023, with most of that volume attributed to cross-border purchasing rather than street sales. Some industry studies use broader off-channel definitions and put the figure above 50%. Meanwhile, French Customs seized 547.94 tonnes of tobacco in 2025, up 12%, showing continued pressure from illicit trade.
Sep.04
PMI's IQOS Extends ZAMNA Electronic-Music Partnership to Spain as Vogue España Publishes Branded Content
PMI's IQOS Extends ZAMNA Electronic-Music Partnership to Spain as Vogue España Publishes Branded Content
Philip Morris International's IQOS has extended its partnership with electronic-music event brand ZAMNA to Spain, setting up a House of IQOS at ZAMNA Madrid. Vogue España and Time Out Madrid subsequently published branded content clearly labeled as collaborations with IQOS. PMI has also expanded its company-owned IQOS boutique network in Spain to seven cities this year. The company says IQOS's adjusted heated-tobacco market share in Europe reached 12.6% in the first quarter of 2026, with Spain among its stronger-performing European markets.
Sep.20
 $20 Million, a Permanent Injunction and Distributor Controls: Posh Deal Tightens Illinois Vape Compliance
$20 Million, a Permanent Injunction and Distributor Controls: Posh Deal Tightens Illinois Vape Compliance
An Illinois court ordered three companies tied to Posh vapes to pay $20 million and permanently restricted the sale, marketing and distribution in Illinois of products lacking required FDA authorization. The consent order also imposes downstream distributor controls, age-verification measures and social-media marketing limits, creating a new state-level compliance benchmark for disposable vape businesses.
Regulations
Aug.05
Product | R.J. Reynolds Launches Four Flavored Vuse Pro Pods for Vuse Alto Devices in U.S.
Product | R.J. Reynolds Launches Four Flavored Vuse Pro Pods for Vuse Alto Devices in U.S.
R.J. Reynolds Vapor Company has introduced Vuse Pro prefilled pods in Peach, Berry, Watermelon and Fresh Mint in selected U.S. states. Vuse’s U.S. website says the pods are intended for use with existing Vuse Alto devices. Each contains 2.0 mL of e-liquid at 5.0% nicotine by weight, uses nicotine salts and is offered in two- and four-pod packs. Reynolds said the rollout includes mandatory ID scanning for every purchase, purchase limits, stronger retailer-accountability requirements and strict age-restricted marketing standards. The four pods have not received marketing authorization from the U.S. Food and Drug Administration.
Sep.10
Charlie’s Says 30 PACHA Vape SKUs Tentatively Identified for FDA’s Non-Priority Enforcement Public List
Charlie’s Says 30 PACHA Vape SKUs Tentatively Identified for FDA’s Non-Priority Enforcement Public List
Charlie’s Holdings said the U.S. Food and Drug Administration notified the company on June 23, 2026, that 30 PACHA vape SKUs with submitted PMTAs had been tentatively identified for inclusion on a planned public-facing FDA webpage. Under enforcement guidance issued by FDA in May, the webpage is intended to identify certain unauthorized products for which the agency generally does not intend to prioritize enforcement of premarket authorization requirements. Charlie’s disclosed the development alongside second-quarter revenue of $3.8 million, up 116% year over year.
Aug.25